Evidence map›Paper›PMID 34367088›Full record

ArticleFrontiers in microbiology2021

The DmsABC Sulfoxide Reductase Supports Virulence in Non-typeable

Rabeb Dhouib, Marufa Nasreen, Dk Seti Maimonah Pg Othman, Daniel Ellis, Simon Lee, Ama-Tawiah Essilfie, Philip M Hansbro, Alastair G McEwan, Ulrike Kappler

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. A novel real-time PCR assay for the simultaneous detection of the four main causes of bacterial meningitis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Article
  5. Article
  6. Journal of bacteriology · 2025
    Review
  7. Article
  8. Frontiers in microbiology · 2025
    Article
  9. Hfe Permease andACS infectious diseases · 2024
    Article
  10. Article
  11. Microbiology spectrum · 2023
    Article
  12. The Peptide Methionine Sulfoxide Reductase (MsrAB) ofAntioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rabeb DhouibSchool of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Marufa NasreenSchool of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Dk Seti Maimonah Pg OthmanSchool of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Daniel EllisSchool of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Simon LeeSchool of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Ama-Tawiah EssilfieQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Philip M HansbroCentre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
Alastair G McEwanSchool of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.
Ulrike KapplerSchool of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.
University of Queensland · AUQIMR Berghofer Medical Research Institute · AUUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although molybdenum-containing enzymes are well-established as having a key role in bacterial respiration, it is increasingly recognized that some may also support bacterial virulence. Here, we show that DmsABC, a putative dimethylsulfoxide (DMSO) reductase, is required for fitness of the respiratory pathogen

Indexed as

anaerobic respirationenergy generationHaemophilus influenzaemolybdenum enzymerespiratory pathogensulfoxidesulfoxide reductase

Identifiers

PMID34367088
PMCPMC8340005
OpenAlexW3184283354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.